High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: Comparison of two methods

Transplantation Proceedings

Volumn 38, Issue 1, 2006, Pages 78-80

  Zochowska, D ^a   Bartlomiejczyk I ^a   Kaminska A ^a   Senatorski, G ^a   Paczek L ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

BLOOD ANALYSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURGICAL PATIENT;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIROLIMUS;

EID: 33644543768     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.12.008     Document Type: Conference Paper

References (6)

1. S.N. Sehgal Rapamune (RAPA, rapamycine, sirolimus) mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression Clin Biochem 31 1998 335
2. P.A. Kelly, S.A. Gruber, F. Behbod Sirolimus, a new, potent immunosuppressive agent Pharmacotherapy 17 1997 1148
3. A. MacDonald, J. Scarola, J.T. Burke Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus Clin Ther 22 Suppl B 2000 101
4. L.J. Aspeslet, R.W. Yatscoff Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation Clin Ther 22 Suppl B 2000 86
5. J.M. Bland, D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307
6. D.W. Holt, M. Moreton, K. Laamanen A microparticle enzyme immunoassay to measure sirolimus Transplant Proc 37 2005 182